Where can I learn more about this study?
You can find more information about this study on the websites listed below. When a full report
of the study results is available, it also can be found here.
> www.clinicaltrials.gov Once you are on the website, type “NCT03682497”
into the search box and click “Search”.
> http://www.clinicaltrialsregister.eu Once you are on the website, click “Home and
Search”, then type “2018-000707-16” in the search box and click “Search”.
> www.AstraZenecaClinicalTrials.com Once you are on the website, type “D6401C00004”
into the search box, and click “Find a Study”.
Full Study Title: A Phase I, Open Label, Randomised, Parallel Group, Multicentre Study to
Compare the Effect of AZD9977 and Spironolactone on Serum Potassium [sK+] during 28 Days in
Patients with HFmrEF or HFpEF and eGFR in the Range of ≥ 40 and ≤ 70 mL/min/1.73 m2
AstraZeneca AB Protocol Number: D6401C00004
National Clinical Trials Number: NCT03682497
EudraCT Number: 2018-000707-16
AstraZeneca sponsored this study and has its headquarters at Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 2.0_2021_09_02
12 | Clinical Study Results